<scp>ZNF582</scp> Inhibits Head and Neck Squamous Cell Carcinoma Progression and Stemness via <scp>MAPK</scp> and <scp>PI3K</scp> / <scp>AKT</scp> Signaling Pathways
Our findings suggested that ZNF582 overexpression inhibits HNSCC progression via the MAPK and PI3K/AKT signaling pathways, highlighting ZNF582 as a potential therapeutic target gene for HNSCC treatment.
Authors
- Lingfei Jia (ORCID: https://orcid.org/0000-0002-1227-1233)
- Zhen Qin (ORCID: https://orcid.org/0000-0003-0421-3938)
- Xin Peng (ORCID: https://orcid.org/0000-0001-8535-1771)
- Wen‐Bo Zhang (ORCID: https://orcid.org/0000-0002-2909-3525)
- Shuo Liu (ORCID: https://orcid.org/0000-0002-3092-7638)
- Ya-Qing Mao (ORCID: https://orcid.org/0009-0004-4537-7925)
Institutions
- Peking University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Peking University People's Hospital (CN)
Publication Details
- Journal
- Journal of Oral Pathology and Medicine
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1111/jop.70079
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00